Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Researchers discover 'promising' new treatment for canine epilepsy
Adding MCT oil to a dried-kibble diet may reduce epileptic seizures and improve a dog's quality of life.
Study highlights the potential of MCT oil for reducing seizures and improving quality of life.

Researchers at the Royal Veterinary College (RVC) have discovered a promising new treatment for hard-to-treat canine epilepsy.

Scientists tested the effects of an oil supplement on seizure frequency in dogs with drug-resistant epilepsy. They found that adding the oil to a dog's existing diet reduced seizures and improved quality of life for both dog and owner.

The research was funded by The American Kennel Club Canine Health Foundation and is published in the Journal of Veterinary Internal Medicine.

Dr Rowena Packer, BBSRC Research Fellow at the RVC said: “Our novel findings indicate that a relatively small change to the diet of dogs’ with hard-to-treat epilepsy can potentially reduce the number of seizures they have, while also improving their medication side effects and overall quality of life.”

The study built on previous research that found the oil contained a specific type of fat (medium-chain triglycerides (MCT)) that could have beneficial effects when added to a dried-kibble diet.

The oil was tested during a rigorous trial, in which 28 dogs received the MCT oil for three months and a placebo oil for three months. Neither the researchers or the dogs' owners knew which oil the dogs were receiving at any given time.

Overall, they observed that dogs had significantly fewer seizures during the MCT phase compared to the placebo phase, and improved owner-reported quality of life.

Dr Packer adds: “Epilepsy is often a challenging and distressing condition for dog owners to manage, particularly when dogs don’t respond to anti-seizure medications in the way their owner and vet might have expected or hoped.

“Historically, diet has not been considered a key part of epilepsy management, but along with other recent findings, these results indicate that nutrition likely plays an important role in seizure control.”

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.